It has been a mixed year for Evolent Health, Inc. insiders: $38,000 bought by one person and $329,000 sold by one, so more selling than buying overall.
Springstubb Brendan B (Director) made the biggest buy, worth around $38,000.
On the institutional side, 199 funds reported holding EVH at the end of Q2 2026, and funds were split between buying and selling. Quarter by quarter: Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | McCarthy Daniel Joseph | President | Sell | 65,892 | $5.00 | $329K | SEC |
| Nov 19, 2025 | Springstubb Brendan B | Director | Buy | 10,000 | $3.82 | $38K | SEC |
| Mar 10, 2025 | Holder Diane | Director | Buy | 2,735 | $9.33 | $26K | SEC |
| Mar 10, 2025 | McCarthy Daniel Joseph | President | Buy | 11,040 | $9.01 | $99K | SEC |
| Mar 10, 2025 | Jelinek Richard M | Director | Buy | 15,000 | $9.09 | $136K | SEC |
| Mar 10, 2025 | Jelinek Richard M | Director | Buy | 15,000 | $9.16 | $137K | SEC |
| Mar 10, 2025 | GRUA PETER J | Director | Buy | 11,040 | $9.01 | $99K | SEC |
| Mar 10, 2025 | Blackley Seth | CEO | Buy | 55,225 | $9.01 | $498K | SEC |
| Mar 10, 2025 | Springstubb Brendan B | Director | Buy | 15,000 | $9.27 | $139K | SEC |
| Mar 10, 2025 | Glass Russell Monroe | Director | Buy | 5,400 | $9.27 | $50K | SEC |
| Mar 10, 2025 | KECK KIM | Director | Buy | 10,540 | $9.44 | $99K | SEC |
| Mar 10, 2025 | Barbarosh Craig A. | Director | Buy | 2,000 | $8.81 | $18K | SEC |
| Mar 5, 2025 | Springstubb Brendan B | Director | Buy | 5,000 | $8.75 | $44K | SEC |
| Aug 26, 2024 | Johnson John Paul | CFO | Sell | 44,693 | $30.00 | $1.3M | SEC |
| Aug 26, 2024 | Rafferty Emily Ann | COO | Sell | 8,861 | $30.00 | $266K | SEC |
In the last 12 months Evolent Health, Inc. insiders made open-market purchases worth about $38,000 and sales worth about $329,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in EVH was filed on 2026-08-28.
199 investment managers reported holding EVH in SEC Form 13F filings for Q2 2026.
No congressional trades in EVH were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).